nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2C8—Mometasone—systemic scleroderma	0.219	0.468	CbGbCtD
Montelukast—CYP2C9—Leflunomide—systemic scleroderma	0.0985	0.21	CbGbCtD
Montelukast—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0872	0.186	CbGbCtD
Montelukast—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0354	0.0755	CbGbCtD
Montelukast—CYP3A4—Prednisone—systemic scleroderma	0.0283	0.0604	CbGbCtD
Montelukast—CYP2C9—cardial valve—systemic scleroderma	0.0266	0.361	CbGeAlD
Montelukast—CYSLTR1—smooth muscle tissue—systemic scleroderma	0.00547	0.0744	CbGeAlD
Montelukast—PTGS1—artery—systemic scleroderma	0.00364	0.0495	CbGeAlD
Montelukast—ALOX5—connective tissue—systemic scleroderma	0.00362	0.0493	CbGeAlD
Montelukast—CYSLTR1—lung—systemic scleroderma	0.00361	0.0491	CbGeAlD
Montelukast—ALOX5—smooth muscle tissue—systemic scleroderma	0.00331	0.0451	CbGeAlD
Montelukast—PTGS1—endothelium—systemic scleroderma	0.00307	0.0418	CbGeAlD
Montelukast—PTGS1—blood vessel—systemic scleroderma	0.00284	0.0386	CbGeAlD
Montelukast—ALOX5—digestive system—systemic scleroderma	0.00262	0.0356	CbGeAlD
Montelukast—ALOX5—lung—systemic scleroderma	0.00218	0.0297	CbGeAlD
Montelukast—SLCO2B1—digestive system—systemic scleroderma	0.00201	0.0274	CbGeAlD
Montelukast—CYP2A6—lung—systemic scleroderma	0.00193	0.0262	CbGeAlD
Montelukast—SLCO2B1—tendon—systemic scleroderma	0.00192	0.0261	CbGeAlD
Montelukast—SLCO2B1—lung—systemic scleroderma	0.00168	0.0229	CbGeAlD
Montelukast—PTGS1—connective tissue—systemic scleroderma	0.00145	0.0198	CbGeAlD
Montelukast—PTGS1—smooth muscle tissue—systemic scleroderma	0.00133	0.0181	CbGeAlD
Montelukast—PTGS1—skin of body—systemic scleroderma	0.00131	0.0179	CbGeAlD
Montelukast—CYP2C9—digestive system—systemic scleroderma	0.00115	0.0156	CbGeAlD
Montelukast—PTGS1—digestive system—systemic scleroderma	0.00105	0.0143	CbGeAlD
Montelukast—PTGS1—tendon—systemic scleroderma	0.000999	0.0136	CbGeAlD
Montelukast—CYP3A4—digestive system—systemic scleroderma	0.000877	0.0119	CbGeAlD
Montelukast—PTGS1—lung—systemic scleroderma	0.000877	0.0119	CbGeAlD
Montelukast—Tremor—Lisinopril—systemic scleroderma	0.000563	0.00123	CcSEcCtD
Montelukast—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000561	0.00122	CcSEcCtD
Montelukast—Nervous system disorder—Leflunomide—systemic scleroderma	0.000559	0.00122	CcSEcCtD
Montelukast—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000558	0.00122	CcSEcCtD
Montelukast—Pruritus—Mometasone—systemic scleroderma	0.000557	0.00122	CcSEcCtD
Montelukast—Skin disorder—Leflunomide—systemic scleroderma	0.000554	0.00121	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00055	0.0012	CcSEcCtD
Montelukast—Angioedema—Lisinopril—systemic scleroderma	0.000549	0.0012	CcSEcCtD
Montelukast—Body temperature increased—Captopril—systemic scleroderma	0.000547	0.00119	CcSEcCtD
Montelukast—Abdominal pain—Captopril—systemic scleroderma	0.000547	0.00119	CcSEcCtD
Montelukast—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00119	CcSEcCtD
Montelukast—Oedema—Mycophenolic acid—systemic scleroderma	0.000544	0.00119	CcSEcCtD
Montelukast—Nausea—Pentoxifylline—systemic scleroderma	0.000542	0.00118	CcSEcCtD
Montelukast—Infection—Mycophenolic acid—systemic scleroderma	0.00054	0.00118	CcSEcCtD
Montelukast—Diarrhoea—Mometasone—systemic scleroderma	0.000539	0.00118	CcSEcCtD
Montelukast—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000534	0.00116	CcSEcCtD
Montelukast—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000533	0.00116	CcSEcCtD
Montelukast—Palpitations—Lisinopril—systemic scleroderma	0.000531	0.00116	CcSEcCtD
Montelukast—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000529	0.00116	CcSEcCtD
Montelukast—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000528	0.00115	CcSEcCtD
Montelukast—Cough—Lisinopril—systemic scleroderma	0.000524	0.00114	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000522	0.00114	CcSEcCtD
Montelukast—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000521	0.00114	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00052	0.00113	CcSEcCtD
Montelukast—Insomnia—Leflunomide—systemic scleroderma	0.000516	0.00113	CcSEcCtD
Montelukast—Paraesthesia—Leflunomide—systemic scleroderma	0.000512	0.00112	CcSEcCtD
Montelukast—Arthralgia—Lisinopril—systemic scleroderma	0.000511	0.00112	CcSEcCtD
Montelukast—Myalgia—Lisinopril—systemic scleroderma	0.000511	0.00112	CcSEcCtD
Montelukast—Anxiety—Lisinopril—systemic scleroderma	0.000509	0.00111	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000508	0.00111	CcSEcCtD
Montelukast—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000506	0.0011	CcSEcCtD
Montelukast—Dyspepsia—Leflunomide—systemic scleroderma	0.000502	0.0011	CcSEcCtD
Montelukast—Pancreatitis—Prednisone—systemic scleroderma	0.000502	0.0011	CcSEcCtD
Montelukast—Vomiting—Mometasone—systemic scleroderma	0.000501	0.00109	CcSEcCtD
Montelukast—Rash—Mometasone—systemic scleroderma	0.000497	0.00108	CcSEcCtD
Montelukast—Asthenia—Captopril—systemic scleroderma	0.000496	0.00108	CcSEcCtD
Montelukast—Dermatitis—Mometasone—systemic scleroderma	0.000496	0.00108	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000496	0.00108	CcSEcCtD
Montelukast—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000494	0.00108	CcSEcCtD
Montelukast—Headache—Mometasone—systemic scleroderma	0.000494	0.00108	CcSEcCtD
Montelukast—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00108	CcSEcCtD
Montelukast—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000492	0.00107	CcSEcCtD
Montelukast—Insomnia—Mycophenolic acid—systemic scleroderma	0.000492	0.00107	CcSEcCtD
Montelukast—Fatigue—Leflunomide—systemic scleroderma	0.000492	0.00107	CcSEcCtD
Montelukast—Oedema—Lisinopril—systemic scleroderma	0.00049	0.00107	CcSEcCtD
Montelukast—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00049	0.00107	CcSEcCtD
Montelukast—Pruritus—Captopril—systemic scleroderma	0.00049	0.00107	CcSEcCtD
Montelukast—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000489	0.00107	CcSEcCtD
Montelukast—Pain—Leflunomide—systemic scleroderma	0.000488	0.00106	CcSEcCtD
Montelukast—Infection—Lisinopril—systemic scleroderma	0.000487	0.00106	CcSEcCtD
Montelukast—Somnolence—Mycophenolic acid—systemic scleroderma	0.000484	0.00106	CcSEcCtD
Montelukast—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00106	CcSEcCtD
Montelukast—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00105	CcSEcCtD
Montelukast—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00048	0.00105	CcSEcCtD
Montelukast—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000479	0.00105	CcSEcCtD
Montelukast—Abdominal pain—Azathioprine—systemic scleroderma	0.000477	0.00104	CcSEcCtD
Montelukast—Body temperature increased—Azathioprine—systemic scleroderma	0.000477	0.00104	CcSEcCtD
Montelukast—Skin disorder—Lisinopril—systemic scleroderma	0.000476	0.00104	CcSEcCtD
Montelukast—Diarrhoea—Captopril—systemic scleroderma	0.000473	0.00103	CcSEcCtD
Montelukast—Irritability—Methotrexate—systemic scleroderma	0.000472	0.00103	CcSEcCtD
Montelukast—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00047	0.00103	CcSEcCtD
Montelukast—Fatigue—Mycophenolic acid—systemic scleroderma	0.000469	0.00102	CcSEcCtD
Montelukast—Nausea—Mometasone—systemic scleroderma	0.000468	0.00102	CcSEcCtD
Montelukast—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000466	0.00102	CcSEcCtD
Montelukast—Pain—Mycophenolic acid—systemic scleroderma	0.000465	0.00102	CcSEcCtD
Montelukast—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00101	CcSEcCtD
Montelukast—Cough—Mycophenolate mofetil—systemic scleroderma	0.000459	0.001	CcSEcCtD
Montelukast—Dizziness—Captopril—systemic scleroderma	0.000458	0.000999	CcSEcCtD
Montelukast—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000995	CcSEcCtD
Montelukast—Urticaria—Leflunomide—systemic scleroderma	0.000453	0.000989	CcSEcCtD
Montelukast—Body temperature increased—Leflunomide—systemic scleroderma	0.000451	0.000984	CcSEcCtD
Montelukast—Abdominal pain—Leflunomide—systemic scleroderma	0.000451	0.000984	CcSEcCtD
Montelukast—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000978	CcSEcCtD
Montelukast—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000978	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000447	0.000976	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000446	0.000975	CcSEcCtD
Montelukast—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000974	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000446	0.000973	CcSEcCtD
Montelukast—Hypersensitivity—Azathioprine—systemic scleroderma	0.000445	0.000971	CcSEcCtD
Montelukast—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000445	0.000971	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000971	CcSEcCtD
Montelukast—Insomnia—Lisinopril—systemic scleroderma	0.000443	0.000968	CcSEcCtD
Montelukast—Paraesthesia—Lisinopril—systemic scleroderma	0.00044	0.000961	CcSEcCtD
Montelukast—Vomiting—Captopril—systemic scleroderma	0.00044	0.00096	CcSEcCtD
Montelukast—Rash—Captopril—systemic scleroderma	0.000436	0.000952	CcSEcCtD
Montelukast—Dermatitis—Captopril—systemic scleroderma	0.000436	0.000952	CcSEcCtD
Montelukast—Somnolence—Lisinopril—systemic scleroderma	0.000436	0.000951	CcSEcCtD
Montelukast—Headache—Captopril—systemic scleroderma	0.000433	0.000946	CcSEcCtD
Montelukast—Dyspepsia—Lisinopril—systemic scleroderma	0.000431	0.000942	CcSEcCtD
Montelukast—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00043	0.000939	CcSEcCtD
Montelukast—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00043	0.000939	CcSEcCtD
Montelukast—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000429	0.000937	CcSEcCtD
Montelukast—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000429	0.000937	CcSEcCtD
Montelukast—Asthma—Methotrexate—systemic scleroderma	0.000428	0.000934	CcSEcCtD
Montelukast—Infection—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000931	CcSEcCtD
Montelukast—Eosinophilia—Methotrexate—systemic scleroderma	0.000423	0.000924	CcSEcCtD
Montelukast—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000423	0.000924	CcSEcCtD
Montelukast—Fatigue—Lisinopril—systemic scleroderma	0.000422	0.000922	CcSEcCtD
Montelukast—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000919	CcSEcCtD
Montelukast—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00042	0.000918	CcSEcCtD
Montelukast—Hypersensitivity—Leflunomide—systemic scleroderma	0.00042	0.000917	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—systemic scleroderma	0.000419	0.000915	CcSEcCtD
Montelukast—Pain—Lisinopril—systemic scleroderma	0.000419	0.000915	CcSEcCtD
Montelukast—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000417	0.00091	CcSEcCtD
Montelukast—Diarrhoea—Azathioprine—systemic scleroderma	0.000413	0.000902	CcSEcCtD
Montelukast—Nausea—Captopril—systemic scleroderma	0.000411	0.000897	CcSEcCtD
Montelukast—Asthenia—Leflunomide—systemic scleroderma	0.000409	0.000893	CcSEcCtD
Montelukast—Hallucination—Prednisone—systemic scleroderma	0.000408	0.00089	CcSEcCtD
Montelukast—Pruritus—Leflunomide—systemic scleroderma	0.000403	0.000881	CcSEcCtD
Montelukast—Connective tissue disorder—Prednisone—systemic scleroderma	0.000403	0.000879	CcSEcCtD
Montelukast—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000401	0.000875	CcSEcCtD
Montelukast—Dizziness—Azathioprine—systemic scleroderma	0.000399	0.000872	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000398	0.000868	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000854	CcSEcCtD
Montelukast—Asthenia—Mycophenolic acid—systemic scleroderma	0.00039	0.000852	CcSEcCtD
Montelukast—Diarrhoea—Leflunomide—systemic scleroderma	0.00039	0.000852	CcSEcCtD
Montelukast—Urticaria—Lisinopril—systemic scleroderma	0.000389	0.00085	CcSEcCtD
Montelukast—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000848	CcSEcCtD
Montelukast—Body temperature increased—Lisinopril—systemic scleroderma	0.000387	0.000846	CcSEcCtD
Montelukast—Abdominal pain—Lisinopril—systemic scleroderma	0.000387	0.000846	CcSEcCtD
Montelukast—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000842	CcSEcCtD
Montelukast—Pruritus—Mycophenolic acid—systemic scleroderma	0.000385	0.00084	CcSEcCtD
Montelukast—Vomiting—Azathioprine—systemic scleroderma	0.000384	0.000838	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—systemic scleroderma	0.000384	0.000837	CcSEcCtD
Montelukast—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000833	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—systemic scleroderma	0.000381	0.000833	CcSEcCtD
Montelukast—Infestation—Methotrexate—systemic scleroderma	0.000381	0.000833	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—systemic scleroderma	0.000381	0.000833	CcSEcCtD
Montelukast—Rash—Azathioprine—systemic scleroderma	0.000381	0.000831	CcSEcCtD
Montelukast—Dermatitis—Azathioprine—systemic scleroderma	0.00038	0.00083	CcSEcCtD
Montelukast—Headache—Azathioprine—systemic scleroderma	0.000378	0.000826	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000378	0.000825	CcSEcCtD
Montelukast—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000825	CcSEcCtD
Montelukast—Dizziness—Leflunomide—systemic scleroderma	0.000377	0.000823	CcSEcCtD
Montelukast—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000372	0.000813	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—systemic scleroderma	0.000371	0.000809	CcSEcCtD
Montelukast—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000809	CcSEcCtD
Montelukast—Immune system disorder—Prednisone—systemic scleroderma	0.00037	0.000808	CcSEcCtD
Montelukast—Pain—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000802	CcSEcCtD
Montelukast—Vomiting—Leflunomide—systemic scleroderma	0.000363	0.000792	CcSEcCtD
Montelukast—Hypersensitivity—Lisinopril—systemic scleroderma	0.000361	0.000788	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000361	0.000787	CcSEcCtD
Montelukast—Dizziness—Mycophenolic acid—systemic scleroderma	0.00036	0.000785	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—systemic scleroderma	0.00036	0.000785	CcSEcCtD
Montelukast—Rash—Leflunomide—systemic scleroderma	0.00036	0.000785	CcSEcCtD
Montelukast—Dermatitis—Leflunomide—systemic scleroderma	0.000359	0.000784	CcSEcCtD
Montelukast—Mental disorder—Prednisone—systemic scleroderma	0.000359	0.000783	CcSEcCtD
Montelukast—Nausea—Azathioprine—systemic scleroderma	0.000359	0.000783	CcSEcCtD
Montelukast—Headache—Leflunomide—systemic scleroderma	0.000357	0.00078	CcSEcCtD
Montelukast—Asthenia—Lisinopril—systemic scleroderma	0.000352	0.000768	CcSEcCtD
Montelukast—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000766	CcSEcCtD
Montelukast—Pruritus—Lisinopril—systemic scleroderma	0.000347	0.000757	CcSEcCtD
Montelukast—Vomiting—Mycophenolic acid—systemic scleroderma	0.000346	0.000755	CcSEcCtD
Montelukast—Rash—Mycophenolic acid—systemic scleroderma	0.000343	0.000749	CcSEcCtD
Montelukast—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000343	0.000748	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—systemic scleroderma	0.000342	0.000747	CcSEcCtD
Montelukast—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000745	CcSEcCtD
Montelukast—Headache—Mycophenolic acid—systemic scleroderma	0.000341	0.000744	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—systemic scleroderma	0.00034	0.000742	CcSEcCtD
Montelukast—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000741	CcSEcCtD
Montelukast—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000741	CcSEcCtD
Montelukast—Nausea—Leflunomide—systemic scleroderma	0.000339	0.00074	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000338	0.000738	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—systemic scleroderma	0.000336	0.000733	CcSEcCtD
Montelukast—Diarrhoea—Lisinopril—systemic scleroderma	0.000335	0.000732	CcSEcCtD
Montelukast—Agitation—Prednisone—systemic scleroderma	0.000328	0.000715	CcSEcCtD
Montelukast—Angioedema—Prednisone—systemic scleroderma	0.000326	0.000711	CcSEcCtD
Montelukast—Dizziness—Lisinopril—systemic scleroderma	0.000324	0.000707	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—systemic scleroderma	0.000324	0.000707	CcSEcCtD
Montelukast—Nausea—Mycophenolic acid—systemic scleroderma	0.000323	0.000705	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—systemic scleroderma	0.000318	0.000694	CcSEcCtD
Montelukast—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000691	CcSEcCtD
Montelukast—Vomiting—Lisinopril—systemic scleroderma	0.000312	0.00068	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—systemic scleroderma	0.000309	0.000675	CcSEcCtD
Montelukast—Rash—Lisinopril—systemic scleroderma	0.000309	0.000675	CcSEcCtD
Montelukast—Convulsion—Prednisone—systemic scleroderma	0.000309	0.000674	CcSEcCtD
Montelukast—Dermatitis—Lisinopril—systemic scleroderma	0.000309	0.000674	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000309	0.000674	CcSEcCtD
Montelukast—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000672	CcSEcCtD
Montelukast—Headache—Lisinopril—systemic scleroderma	0.000307	0.00067	CcSEcCtD
Montelukast—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000663	CcSEcCtD
Montelukast—Myalgia—Prednisone—systemic scleroderma	0.000304	0.000663	CcSEcCtD
Montelukast—Arthralgia—Prednisone—systemic scleroderma	0.000304	0.000663	CcSEcCtD
Montelukast—Anxiety—Prednisone—systemic scleroderma	0.000303	0.00066	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000301	0.000658	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—systemic scleroderma	0.0003	0.000655	CcSEcCtD
Montelukast—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000641	CcSEcCtD
Montelukast—Nausea—Lisinopril—systemic scleroderma	0.000291	0.000635	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisone—systemic scleroderma	0.000291	0.000635	CcSEcCtD
Montelukast—Oedema—Prednisone—systemic scleroderma	0.000291	0.000635	CcSEcCtD
Montelukast—Infection—Prednisone—systemic scleroderma	0.000289	0.000631	CcSEcCtD
Montelukast—Nervous system disorder—Prednisone—systemic scleroderma	0.000285	0.000623	CcSEcCtD
Montelukast—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00062	CcSEcCtD
Montelukast—Skin disorder—Prednisone—systemic scleroderma	0.000283	0.000617	CcSEcCtD
Montelukast—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000596	CcSEcCtD
Montelukast—Rash—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000591	CcSEcCtD
Montelukast—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00059	CcSEcCtD
Montelukast—Headache—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000587	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000265	0.000579	CcSEcCtD
Montelukast—Insomnia—Prednisone—systemic scleroderma	0.000263	0.000575	CcSEcCtD
Montelukast—Paraesthesia—Prednisone—systemic scleroderma	0.000261	0.000571	CcSEcCtD
Montelukast—Cough—Methotrexate—systemic scleroderma	0.00026	0.000568	CcSEcCtD
Montelukast—Convulsion—Methotrexate—systemic scleroderma	0.000258	0.000564	CcSEcCtD
Montelukast—Dyspepsia—Prednisone—systemic scleroderma	0.000256	0.000559	CcSEcCtD
Montelukast—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000557	CcSEcCtD
Montelukast—Myalgia—Methotrexate—systemic scleroderma	0.000254	0.000554	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—systemic scleroderma	0.000254	0.000554	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000252	0.00055	CcSEcCtD
Montelukast—Fatigue—Prednisone—systemic scleroderma	0.000251	0.000548	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000243	0.000531	CcSEcCtD
Montelukast—Infection—Methotrexate—systemic scleroderma	0.000242	0.000528	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—systemic scleroderma	0.000239	0.000521	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000238	0.00052	CcSEcCtD
Montelukast—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000238	0.00052	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—systemic scleroderma	0.000236	0.000516	CcSEcCtD
Montelukast—Urticaria—Prednisone—systemic scleroderma	0.000231	0.000505	CcSEcCtD
Montelukast—Abdominal pain—Prednisone—systemic scleroderma	0.00023	0.000502	CcSEcCtD
Montelukast—Body temperature increased—Prednisone—systemic scleroderma	0.00023	0.000502	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000222	0.000484	CcSEcCtD
Montelukast—Insomnia—Methotrexate—systemic scleroderma	0.00022	0.00048	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—systemic scleroderma	0.000218	0.000477	CcSEcCtD
Montelukast—Somnolence—Methotrexate—systemic scleroderma	0.000216	0.000472	CcSEcCtD
Montelukast—Hypersensitivity—Prednisone—systemic scleroderma	0.000214	0.000468	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—systemic scleroderma	0.000214	0.000467	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00021	0.000458	CcSEcCtD
Montelukast—Fatigue—Methotrexate—systemic scleroderma	0.00021	0.000458	CcSEcCtD
Montelukast—Asthenia—Prednisone—systemic scleroderma	0.000209	0.000456	CcSEcCtD
Montelukast—Pain—Methotrexate—systemic scleroderma	0.000208	0.000454	CcSEcCtD
Montelukast—Pruritus—Prednisone—systemic scleroderma	0.000206	0.00045	CcSEcCtD
Montelukast—Diarrhoea—Prednisone—systemic scleroderma	0.000199	0.000435	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000199	0.000434	CcSEcCtD
Montelukast—Urticaria—Methotrexate—systemic scleroderma	0.000193	0.000422	CcSEcCtD
Montelukast—Dizziness—Prednisone—systemic scleroderma	0.000192	0.00042	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—systemic scleroderma	0.000192	0.00042	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—systemic scleroderma	0.000192	0.00042	CcSEcCtD
Montelukast—Vomiting—Prednisone—systemic scleroderma	0.000185	0.000404	CcSEcCtD
Montelukast—Rash—Prednisone—systemic scleroderma	0.000183	0.000401	CcSEcCtD
Montelukast—Dermatitis—Prednisone—systemic scleroderma	0.000183	0.0004	CcSEcCtD
Montelukast—Headache—Prednisone—systemic scleroderma	0.000182	0.000398	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—systemic scleroderma	0.000179	0.000391	CcSEcCtD
Montelukast—Asthenia—Methotrexate—systemic scleroderma	0.000175	0.000381	CcSEcCtD
Montelukast—Nausea—Prednisone—systemic scleroderma	0.000173	0.000377	CcSEcCtD
Montelukast—Pruritus—Methotrexate—systemic scleroderma	0.000172	0.000376	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—systemic scleroderma	0.000166	0.000363	CcSEcCtD
Montelukast—Dizziness—Methotrexate—systemic scleroderma	0.000161	0.000351	CcSEcCtD
Montelukast—Vomiting—Methotrexate—systemic scleroderma	0.000155	0.000338	CcSEcCtD
Montelukast—Rash—Methotrexate—systemic scleroderma	0.000153	0.000335	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—systemic scleroderma	0.000153	0.000334	CcSEcCtD
Montelukast—Headache—Methotrexate—systemic scleroderma	0.000152	0.000333	CcSEcCtD
Montelukast—Nausea—Methotrexate—systemic scleroderma	0.000144	0.000315	CcSEcCtD
